Page last updated: 2024-09-03

op 2507 and malondialdehyde

op 2507 has been researched along with malondialdehyde in 1 studies

Compound Research Comparison

Studies (op 2507)	Trials (op 2507)	Recent Studies (post-2010) (op 2507)	Studies (malondialdehyde)	Trials (malondialdehyde)	Recent Studies (post-2010) (malondialdehyde)
33	0	1	27,849	1,405	13,922

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, HM; Chen, MF; Shyr, MH	1

Other Studies

1 other study(ies) available for op 2507 and malondialdehyde

Article	Year
Prostacyclin analogue (OP-2507) attenuates hepatic microcirculatory derangement, energy depletion, and lipid peroxidation in a rat model of reperfusion injury. The Journal of surgical research, 1998, Volume: 80, Issue:2 Topics: Adenosine Triphosphate; Animals; Blood Flow Velocity; Blood Pressure; Disease Models, Animal; Energy Metabolism; Epoprostenol; Infusions, Intravenous; Leukocytes; Lipid Peroxidation; Liver; Liver Circulation; Male; Malondialdehyde; Microcirculation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors	1998

Article

Year

Prostacyclin analogue (OP-2507) attenuates hepatic microcirculatory derangement, energy depletion, and lipid peroxidation in a rat model of reperfusion injury.

The Journal of surgical research, 1998, Volume: 80, Issue:2

Topics: Adenosine Triphosphate; Animals; Blood Flow Velocity; Blood Pressure; Disease Models, Animal; Energy Metabolism; Epoprostenol; Infusions, Intravenous; Leukocytes; Lipid Peroxidation; Liver; Liver Circulation; Male; Malondialdehyde; Microcirculation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors

1998